𝔖 Bobbio Scriptorium
✦   LIBER   ✦

B cell–ablative therapy for the treatment of autoimmune diseases

✍ Scribed by Dhavalkumar D. Patel

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
31 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New prospects for autoimmune disease the
New prospects for autoimmune disease therapy: B cells on deathwatch
✍ E. William St.Clair; Thomas F. Tedder 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Dr. St.Clair has served on the advisory boards of Genentech, Cellective Therapeutics (now owned by MedImmune), and Human Genome Sciences. Dr. Tedder has Tedder has received consulting fees (more than $10,000 per year) from Cellective Therapeutics (now owned by MedImmune), has given expert testimony

The Epigenetics of Autoimmune Diseases (
The Epigenetics of Autoimmune Diseases (Zouali/The Epigenetics of Autoimmune Diseases) || Regulation of T Cell Anergy and Escape from Regulatory T Cell Suppression by Cbl-b
✍ Zouali, Moncef 📂 Article 📅 2009 🏛 John Wiley & Sons, Ltd 🌐 English ⚖ 373 KB

The Role Of Epigenetic Mechanisms In Autoimmune Disease Is Only Now Starting To Become Clear. Understanding These Mechanisms, Their Effect On Cellular Function And The Role Of Environmental Factors Is Vital To Determining How To Manage These Often Debilitating And Fatal Diseases. drawing On The Res

Development of gene therapy-based strate
Development of gene therapy-based strategies for the treatment of eye diseases
✍ Piroska E. Rakoczy; Wei-Yong Shen; May Lai; Fabienne Rolling; Ian J. Constable 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Gene therapy, which is the deliberate transfer of DNA for therapeutic purposes, can be defined as the in situ production of a therapeutical material within the diseased cells. The eye is an ideal target for gene therapy, as it is confined to a small space, separated by the retina-blood barrier from